286 related articles for article (PubMed ID: 9678800)
61. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
62. [Pulmonary complications occurring after allogeneic bone marrow transplantation].
Fan Y; Guo N; Huang X
Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):409-12. PubMed ID: 11189507
[TBL] [Abstract][Full Text] [Related]
63. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
Hasegawa S; Horibe K; Kawabe T; Kato K; Kojima S; Matsuyama T; Hirabayashi N
Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723
[TBL] [Abstract][Full Text] [Related]
64. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281
[TBL] [Abstract][Full Text] [Related]
65. Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
Bonnotte B; Burdiles AM; Chehimi J; Carayol G; Pardoux C; Dietrich PY; Kubin M; Blay JY; Caignard A; Ibrahim A; Robinet E; Hayat M; Pico JL; Bourhis JH; Chouaib S
Eur Cytokine Netw; 1996 Sep; 7(3):389-94. PubMed ID: 8954182
[TBL] [Abstract][Full Text] [Related]
66. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
Schlitt HJ; Tischler HJ; Ringe B; Raddatz G; Maschek H; Dietrich H; Kuse E; Pichlmayr R; Link H
Bone Marrow Transplant; 1995 Sep; 16(3):473-8. PubMed ID: 8535323
[TBL] [Abstract][Full Text] [Related]
67. Post-bone marrow transplant patient management.
Poliquin CM
Yale J Biol Med; 1990; 63(5):495-502. PubMed ID: 2293508
[TBL] [Abstract][Full Text] [Related]
68. Serum cytokine levels in patients undergoing bone marrow transplantation.
Chasty RC; Lamb WR; Gallati H; Roberts TE; Brenchley PE; Yin JA
Bone Marrow Transplant; 1993 Oct; 12(4):331-6. PubMed ID: 8275032
[TBL] [Abstract][Full Text] [Related]
69. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation.
Park YD; Yasui M; Yoshimoto T; Chayama K; Shimono T; Okamura T; Inoue M; Yumura-Yagi K; Kawa-Ha K
Bone Marrow Transplant; 1997 May; 19(9):915-20. PubMed ID: 9156266
[TBL] [Abstract][Full Text] [Related]
70. Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation.
Gluckman E; Jolivet I; Scrobohaci ML; Devergie A; Traineau R; Bourdeau-Espérou H; Lehn P; Faure P; Drouet L
Nouv Rev Fr Hematol (1978); 1990; 32(1):1-3. PubMed ID: 2349075
[TBL] [Abstract][Full Text] [Related]
71. Serum interleukin-6 levels during bone marrow transplantation: impact on transplant-related toxicity and engraftment.
Steffen M; Dürken M; Pichlmeier U; von dem Busche C; Stockschläder M; Krüger W; Budde-Steffen C; Zander A
Bone Marrow Transplant; 1996 Aug; 18(2):301-7. PubMed ID: 8864438
[TBL] [Abstract][Full Text] [Related]
72. Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation.
Morris JD; Harris RE; Hashmi R; Sambrano JE; Gruppo RA; Becker AT; Morris CL
Bone Marrow Transplant; 1997 Nov; 20(10):871-8. PubMed ID: 9404929
[TBL] [Abstract][Full Text] [Related]
73. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation.
Blostein MD; Paltiel OB; Thibault A; Rybka WB
Bone Marrow Transplant; 1992 Nov; 10(5):439-43. PubMed ID: 1464007
[TBL] [Abstract][Full Text] [Related]
74. Lichen planus-like histopathologic characteristics in the cutaneous graft-vs-host reaction. Prognostic significance independent of time course after allogeneic bone marrow transplantation.
Horn TD; Zahurak ML; Atkins D; Solomon AR; Vogelsang GB
Arch Dermatol; 1997 Aug; 133(8):961-5. PubMed ID: 9267240
[TBL] [Abstract][Full Text] [Related]
75. Prognostic role of pre-transplantation serum C-reactive protein levels in patients with acute leukemia undergoing myeloablative allogeneic stem cell transplantation.
Akı ŞZ; Suyanı E; Bildacı Y; Çakar MK; Baysal NA; Sucak GT
Clin Transplant; 2012; 26(5):E513-21. PubMed ID: 23061760
[TBL] [Abstract][Full Text] [Related]
76. Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis.
Ko CW; Gooley T; Schoch HG; Myerson D; Hackman RC; Shulman HM; Sale GE; Lee SP; McDonald GB
Bone Marrow Transplant; 1997 Dec; 20(12):1081-6. PubMed ID: 9466282
[TBL] [Abstract][Full Text] [Related]
77. Chronic cholestasis in patients after allogeneic bone marrow transplantation: several diseases are often associated.
Bertheau P; Hadengue A; Cazals-Hatem D; Devergie A; Schenmetzler C; Degos F; Erlinger S; Gluckman E; Degott C
Bone Marrow Transplant; 1995 Aug; 16(2):261-5. PubMed ID: 7581145
[TBL] [Abstract][Full Text] [Related]
78. Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS).
Lévy V; Azoulay D; Rio B; Vincent F; Rabbat A; Hunault M; Bazarbachi A; Delmer A; Zittoun R
Bone Marrow Transplant; 1996 Aug; 18(2):443-45. PubMed ID: 8864460
[TBL] [Abstract][Full Text] [Related]
79. Plasma protein C is a useful clinical marker for hepatic veno-occlusive disease (VOD) in stem cell transplantation.
Iguchi A; Kobayashi R; Kaneda M; Kobayashi K
Pediatr Blood Cancer; 2010 Mar; 54(3):437-43. PubMed ID: 19911420
[TBL] [Abstract][Full Text] [Related]
80. Alterations in natural anticoagulant levels during allogeneic bone marrow transplantation: a prospective study in 27 patients.
Leblond V; Salehian BD; Borel C; Mapakou CP; Dombret H; Sutton L; Binet JL; Ankri A
Bone Marrow Transplant; 1993 Apr; 11(4):299-305. PubMed ID: 8485478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
